Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #264

Sentinel Lymph Node Biopsy for Invasive Breast Cancer

The percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients before or after neoadjuvant systemic therapy, who undergo a sentinel lymph node (SLN) procedure.

Submission Methods: Registry
Measure Sets: General Surgery

There are no codes for this QPP measure yet (code lists for the current year may not have been established yet).

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.